Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, October 17, 2013
Almac has today announced the launch of a new offering for the provision of [14C]-labelled Antibody Drug Conjugates (ADCs).
read more
Monday, September 17, 2012
Almac has today announced the launch of a new reagent offering based on the provision of homogeneous full length histones with defined patterns of modification. The histone reagents will prove a highly valuable tool for researchers seeking to ...
read more
Tuesday, September 10, 2013
Almac today announced they are now offering a Tumor Profiling service running Illumina’s next-generation sequencing (NGS) TruSight Tumor™ panel as part of their biomarker discovery, development and delivery solutions.
read more
Tuesday, January 28, 2014
Almac’s Diagnostics business unit today announced the publication of its breast cancer chemotherapy response assay in the Journal of the National Cancer Institute (JNCI).
read more
Friday, February 22, 2013
Following from successful MHRA audits in 2011, Almac’s Sciences Business Unit has completed a successful inspection of its analytical facilities at its Craigavon Headquarters, Northern Ireland from the US Food and Drug Administration (FDA). The ...
read more
Almac has been recognised for its cutting edge technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (bmi).
read more
Almac is pleased to announce the successful completion of the Knowledge Transfer Partnership (KTP) with Queens University, Belfast to develop, improve and embed bioprocesses in order to facilitate the delivery of novel products for its biocatalysis ...
read more
Wednesday, September 05, 2012
Alphora is pleased to announce the completion of a GMP Kilo Laboratory, for the scale-up high potency, cytoctoxic compounds with occupational exposure limits (OEL’s) of 10µg/m3 or less. This expansion is a continuation of Alphora’s 2011 capital ...
read more
Wednesday, November 18, 2015
Alphora is pleased to announce the completion of a new 3,000 sq. ft. analytical laboratory expansion.
read more
Alphora is pleased to announce that it has completed $2M in capital investments, adding two Flow Chemistry platforms
and additional process chemistry and analytical technologies to its toolbox. These additions represent a significant
investment for...
read more
Althea Technologies, a leading provider of development and manufacturing services for biopharmaceutical products, today announced that Dennis Fenton, Ph.D., will chair Althea’s Scientific Advisory Board and be appointed as Board Observer. Dr. Fenton ...
read more
AMRI (NYSE: AMRI), a leading global contract research and manufacturing organization, was selected by Biota Holdings Limited (ASX: BTA), a leading anti-infective drug development company based in Australia, to further develop and manufacture the ...
read more
AMRI, a leading global contract research and manufacturing organization, announced today the appointment of Ian Shott as President of AMRI Europe, reporting to Thomas D’Ambra, Ph.D., chairman, president and CEO. In this newly created role, Mr. Shott ...
read more
Monday, September 17, 2012
AMRI announced today that it has entered into a new strategic agreement with Knopp Biosciences LLC, a drug discovery and development company focused on breakthrough treatments for unmet needs in neurological disorders.
read more
As part of a long-term strategic plan to further AMRI’s discovery capabilities in India, AMRI (NASDAQ: AMRI), a leading global contract research and manufacturing organization, announced the hiring of two experts in medicinal and computational ...
read more